Literature DB >> 30520062

Hepatocyte Nuclear Factor 4 Alpha Activation Is Essential for Termination of Liver Regeneration in Mice.

Ian Huck1, Sumedha Gunewardena2, Regina Espanol-Suner3, Holger Willenbring3,4,5, Udayan Apte1.   

Abstract

Hepatocyte nuclear factor 4 alpha (HNF4α) is critical for hepatic differentiation. Recent studies have highlighted its role in inhibition of hepatocyte proliferation and tumor suppression. However, the role of HNF4α in liver regeneration (LR) is not known. We hypothesized that hepatocytes modulate HNF4α activity when navigating between differentiated and proliferative states during LR. Western blotting analysis revealed a rapid decline in nuclear and cytoplasmic HNF4α protein levels, accompanied with decreased target gene expression, within 1 hour after two-thirds partial hepatectomy (post-PH) in C57BL/6J mice. HNF4α protein expression did not recover to pre-PH levels until day 3. Hepatocyte-specific deletion of HNF4α (HNF4α-KO [knockout]) in mice resulted in 100% mortality post-PH, despite increased proliferative marker expression throughout regeneration. Sustained loss of HNF4α target gene expression throughout regeneration indicated that HNF4α-KO mice were unable to compensate for loss of HNF4α transcriptional activity. Deletion of HNF4α resulted in sustained proliferation accompanied by c-Myc and cyclin D1 overexpression and a complete deficiency of hepatocyte function after PH. Interestingly, overexpression of degradation-resistant HNF4α in hepatocytes delayed, but did not prevent, initiation of regeneration after PH. Finally, adeno-associated virus serotype 8 (AAV8)-mediated reexpression of HNF4α in hepatocytes of HNF4α-KO mice post-PH restored HNF4α protein levels, induced target gene expression, and improved survival of HNF4α-KO mice post-PH.
Conclusion: In conclusion, these data indicate that HNF4α reexpression following initial decrease is critical for hepatocytes to exit from cell cycle and resume function during the termination phase of LR. These results indicate the role of HNF4α in LR and have implications for therapy of liver failure.
© 2018 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30520062      PMCID: PMC6551324          DOI: 10.1002/hep.30405

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  50 in total

1.  Plasticity and expanding complexity of the hepatic transcription factor network during liver development.

Authors:  Irene Kyrmizi; Pantelis Hatzis; Nitsa Katrakili; Francois Tronche; Frank J Gonzalez; Iannis Talianidis
Journal:  Genes Dev       Date:  2006-08-15       Impact factor: 11.361

2.  Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis.

Authors:  G P Hayhurst; Y H Lee; G Lambert; J M Ward; F J Gonzalez
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

3.  Defective ureagenesis in mice carrying a liver-specific disruption of hepatocyte nuclear factor 4alpha (HNF4alpha ). HNF4alpha regulates ornithine transcarbamylase in vivo.

Authors:  Yusuke Inoue; Graham P Hayhurst; Junko Inoue; Masataka Mori; Frank J Gonzalez
Journal:  J Biol Chem       Date:  2002-05-06       Impact factor: 5.157

4.  Phosphorylation of a conserved serine in the deoxyribonucleic acid binding domain of nuclear receptors alters intracellular localization.

Authors:  Kai Sun; Vedrana Montana; Karthikeyani Chellappa; Yann Brelivet; Dino Moras; Yutaka Maeda; Vladimir Parpura; Bryce M Paschal; Frances M Sladek
Journal:  Mol Endocrinol       Date:  2007-03-27

5.  Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice.

Authors:  Eyal Shteyer; Yunjun Liao; Louis J Muglia; Paul W Hruz; David A Rudnick
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

6.  Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer.

Authors:  T Tanaka; S Jiang; H Hotta; K Takano; H Iwanari; K Sumi; K Daigo; R Ohashi; M Sugai; C Ikegame; H Umezu; Y Hirayama; Y Midorikawa; Y Hippo; A Watanabe; Y Uchiyama; G Hasegawa; Pc Reid; H Aburatani; T Hamakubo; J Sakai; M Naito; T Kodama
Journal:  J Pathol       Date:  2006-04       Impact factor: 7.996

7.  Zinc finger protein ZBTB20 is a key repressor of alpha-fetoprotein gene transcription in liver.

Authors:  Zhifang Xie; Hai Zhang; Wenwei Tsai; Ye Zhang; Yu Du; Jigen Zhong; Claude Szpirer; Minghua Zhu; Xuetao Cao; Michelle Craig Barton; Michael J Grusby; Weiping J Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-31       Impact factor: 11.205

8.  Nuclear receptor hepatocyte nuclear factor 4alpha1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter.

Authors:  Wendy W Hwang-Verslues; Frances M Sladek
Journal:  Mol Endocrinol       Date:  2007-09-20

Review 9.  Regulation of hepatocyte nuclear factor 4 alpha-mediated transcription.

Authors:  Frank J Gonzalez
Journal:  Drug Metab Pharmacokinet       Date:  2008       Impact factor: 3.614

10.  Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis.

Authors:  Fereshteh Parviz; Christine Matullo; Wendy D Garrison; Laura Savatski; John W Adamson; Gang Ning; Klaus H Kaestner; Jennifer M Rossi; Kenneth S Zaret; Stephen A Duncan
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

View more
  22 in total

Review 1.  Cellular and molecular basis of liver regeneration.

Authors:  Sushant Bangru; Auinash Kalsotra
Journal:  Semin Cell Dev Biol       Date:  2020-01-22       Impact factor: 7.727

Review 2.  Liver regeneration: biological and pathological mechanisms and implications.

Authors:  George K Michalopoulos; Bharat Bhushan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-08-06       Impact factor: 46.802

Review 3.  Receptor Guanylyl Cyclase C and Cyclic GMP in Health and Disease: Perspectives and Therapeutic Opportunities.

Authors:  Hari Prasad; John Kandam Kulathu Mathew; Sandhya S Visweswariah
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-29       Impact factor: 6.055

4.  Farnesoid X receptor (FXR) agonists induce hepatocellular apoptosis and impair hepatic functions via FXR/SHP pathway.

Authors:  Tianwei Zhang; Shanshan Feng; Jiahuan Li; Zhitao Wu; Qiangqiang Deng; Wei Yang; Jing Li; Guoyu Pan
Journal:  Arch Toxicol       Date:  2022-03-10       Impact factor: 6.168

5.  A Western diet with alcohol in drinking water recapitulates features of alcohol-associated liver disease in mice.

Authors:  Michael Schonfeld; Maura O'Neil; Maria T Villar; Antonio Artigues; Janice Averilla; Sumedha Gunewardena; Steven A Weinman; Irina Tikhanovich
Journal:  Alcohol Clin Exp Res       Date:  2021-09-29       Impact factor: 3.928

Review 6.  Therapeutic Potential of HNF4α in End-stage Liver Disease.

Authors:  Ricardo Diaz-Aragon; Michael C Coard; Sriram Amirneni; Lanuza Faccioli; Nils Haep; Michelle R Malizio; Takashi Motomura; Zehra N Kocas-Kilicarslan; Alina Ostrowska; Rodrigo M Florentino; Carla Frau
Journal:  Organogenesis       Date:  2021-10-02       Impact factor: 2.316

7.  A negative reciprocal regulatory axis between cyclin D1 and HNF4α modulates cell cycle progression and metabolism in the liver.

Authors:  Heng Wu; Tzachi Reizel; Yue J Wang; Jessica L Lapiro; Betsy T Kren; Jonathan Schug; Shilpa Rao; Ashleigh Morgan; Adam Herman; Laurie L Shekels; Matthew S Rassette; Andrew N Lane; Teresa Cassel; Teresa W M Fan; Juan C Manivel; Sumedha Gunewardena; Udayan Apte; Piotr Sicinski; Klaus H Kaestner; Jeffrey H Albrecht
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-06       Impact factor: 12.779

8.  Endoplasmic reticulum stress actively suppresses hepatic molecular identity in damaged liver.

Authors:  Céline Gheeraert; Wouter Vankrunkelsven; Julie Dubois-Chevalier; Hélène Dehondt; Philippe Lefebvre; Jérôme Eeckhoute; Vanessa Dubois; Marie Bobowski-Gerard; Manjula Vinod; Francesco Paolo Zummo; Fabian Güiza; Maheul Ploton; Emilie Dorchies; Laurent Pineau; Alexis Boulinguiez; Emmanuelle Vallez; Eloise Woitrain; Eric Baugé; Fanny Lalloyer; Christian Duhem; Nabil Rabhi; Ronald E van Kesteren; Cheng-Ming Chiang; Steve Lancel; Hélène Duez; Jean-Sébastien Annicotte; Réjane Paumelle; Ilse Vanhorebeek; Greet Van den Berghe; Bart Staels
Journal:  Mol Syst Biol       Date:  2020-05       Impact factor: 11.429

9.  Hepatocyte nuclear factor 4α negatively regulates connective tissue growth factor during liver regeneration.

Authors:  Junmei Zhou; Xiaowei Sun; Lu Yang; Liqun Wang; Gai Ran; Jinhui Wang; Qi Cao; Lizi Wu; Andrew Bryant; Chen Ling; Liya Pi
Journal:  FASEB J       Date:  2020-02-14       Impact factor: 5.191

10.  Liver structural transformation after partial hepatectomy and repeated partial hepatectomy in rats: A renewed view on liver regeneration.

Authors:  Keti Tsomaia; Leila Patarashvili; Nino Karumidze; Irakli Bebiashvili; Elza Azmaipharashvili; Irina Modebadze; Diana Dzidziguri; Marom Sareli; Sergey Gusev; Dimitri Kordzaia
Journal:  World J Gastroenterol       Date:  2020-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.